Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells in vitro

Overview of attention for article published in Frontiers in oncology, May 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter: 2 X users

Readers on

mendeley: 31 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 6,710 followers.

New research: Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells in vitro: Sitravatinib, also called MGCD516 or MG-516, is a broad-spectrum… https://t.co/NKu6K

18 Jun 2020

Reply Repost Favourite

Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells in vitro https://t.co/4IgUHPfjqN

28 May 2020

Reply Repost Favourite

Congratulations Zhe-Sheng on your newly published @FrontiersIn article: https://t.co/3kAHq4wS2m

12 May 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.